289701-05-9Relevant academic research and scientific papers
HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR
-
Paragraph 0107; 0108, (2019/05/22)
The present invention provides a heterocyclic compound which is an inhibitor of FGFR4 (fibroblast growth factor receptor 4). Specifically, the present invention provides a compound represented by the following formula (I), including an isomer (enantiomer or diastereomer) which may be present, or a pharmaceutically acceptable salt thereof, prodrugs, deuterated derivatives, hydrates, solvates.The definition of each group in the formula (I) is as described in the specification. The compounds of the present invention has FGFR4 inhibitory activity and can be used for the prevention or treatment of diseases associated with FGFR4 activity or expression, and can also be used in combination with other drugs for the treatment of various related diseases.
